LS

Life Sciences Fund Amsterdam

Europe, Noord-Holland, The Netherlands, Amsterdam

Description

Life Sciences Fund Amsterdam is an investment firm that finances companies, which develop products and technologies in life sciences.

Investor Profile

Life Sciences Fund Amsterdam has made 6 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series A (50%)
  • Series Unknown (33%)
  • Private Equity (17%)

Country Focus

  • The Netherlands (67%)
  • Ireland (17%)
  • United States (17%)

Industry Focus

  • Biotechnology
  • Medical Device
  • Health Care
  • Medical
  • Communities
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Life Sciences Fund Amsterdam frequently co-invest with?

PPM Oost NV
Europe, Gelderland, The Netherlands, Apeldoorn
Co-Investments: 1
Celgene
North America, New Jersey, United States, Summit
Co-Investments: 1
Atlantic Bridge
Europe, Dublin, Ireland, Dublin
Co-Investments: 1
Limburg Ventures
Europe, Limburg, The Netherlands, Maastricht
Co-Investments: 1
Fountain Healthcare Partners
North America, New York, United States, New York
Co-Investments: 1
Western Development Commission
Europe, Roscommon, Ireland, Ballaghaderreen
Co-Investments: 1
Enterprise Ireland
Europe, Dublin, Ireland, Dublin
Co-Investments: 1
6 Dimensions Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Holland Capital
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by Life Sciences Fund Amsterdam?

HiberCell

New York, New York, United States

HiberCell is a clinical-stage biotechnology company dedicated to the advancement of novel therapeutic agents targeting adaptive stress.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series AFeb 7, 2019
Amount Raised: $60,750,000
Neurent Medical

Oranmore, Galway, Ireland

Neurent Medical is a medical device startup that develops non-surgical treatments for inflammatory sino-nasal diseases.

Health CareMedicalMedical Device
Series AMay 28, 2018
Amount Raised: $11,000,000
Sigmascreening

Amsterdam, Noord-Holland, The Netherlands

At Sigmascreening, an Amsterdam based medical device company, they focus on the development of new products in the area of breast cancer

BiotechnologyCommunitiesMedical Device
Private EquityMar 7, 2014
ACS Biomarker

Amsterdam, Noord-Holland, The Netherlands

ACS Biomarker is an emerging biomarker development company aiming to discover and develop biomarkers that improve prognosis and management

Biotechnology
Series UnknownMay 20, 2011
Sigmascreening

Amsterdam, Noord-Holland, The Netherlands

At Sigmascreening, an Amsterdam based medical device company, they focus on the development of new products in the area of breast cancer

BiotechnologyCommunitiesMedical Device
Series AOct 6, 2010
AIMM Therapeutics

Amsterdam, Noord-Holland, The Netherlands

production of monoclonal antibodies by immortalisation of B cells from elite patients.

Biotechnology
Series UnknownJun 3, 2009